PhRMA

PhRMA Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from PhRMA, Medical and health, 670 Maine Avenue SW Ste. 1000, Washington D.C., DC.

We represent America’s innovative biopharmaceutical research & biotechnology companies, advocating for policies that support the discovery of new medicines and ensure broad patient access to safe, effective treatments.

MFN would weaken innovation, siphon billions from R&D and lead to hundreds of fewer lifesaving treatments and cures. Thi...
05/02/2026

MFN would weaken innovation, siphon billions from R&D and lead to hundreds of fewer lifesaving treatments and cures.

This hurts patients, especially the patients and their families who are waiting on cures for life-threatening or rare diseases.

Policymakers must reject MFN and protect cures for American patients.

05/01/2026

The future of medicine is expanding fast.

Scientists may soon be able to discover cures 10 or even 100 times faster than they can today.

04/30/2026

Patients care about getting the medicines they need.

But where those medicines are developed matters.

U.S. leadership means faster access for patients, high-value jobs and stronger national and economic security.

We can’t afford to fall behind.

04/30/2026

America’s biopharmaceutical leadership fuels more than just medicine breakthroughs.

The biopharmaceutical industry fuels jobs, investment and economic growth in every state.

https://ow.ly/2gbK50YSvO6

04/29/2026

For many physicians today, some of the most serious infectious diseases are no longer part of daily practice.

That is the result of decades of progress in vaccination.

But maintaining that progress takes ongoing commitment. As vaccination rates shift and new challenges emerge, it is critical to sustain the policies and investment that support continued innovation and patient protection.

https://ow.ly/342M50YRPUZ

04/27/2026

Babies are not given over 80 vaccines at once.

The childhood schedule protects against 16 diseases and does not overload the immune system.

Vaccines help protect babies when they’re most vulnerable to serious illnesses like measles and polio.

http://phrma.org/vaccines

04/27/2026

Too often in research, scientists unknowingly repeat the same experiments and lose valuable time.

With AI and human expertise working together, we can reduce duplication, improve efficiency and help bring new treatments to patients faster.

Strong IP protections help drive the innovation that improves lives, including in sports medicine.From managing chronic ...
04/26/2026

Strong IP protections help drive the innovation that improves lives, including in sports medicine.

From managing chronic respiratory conditions to supporting recovery from injuries, medical advances play an important role in helping athletes stay healthy and return to play safely.

On World IP Day, we recognize how policies that support innovation continue to enable new treatments and expand what is possible for patients and athletes alike.

PhRMA.org/IP

Minnesota’s own data shows the problem with the 340B hospital markup program: Hospitals made $1.3B+ in 340B profits—near...
04/25/2026

Minnesota’s own data shows the problem with the 340B hospital markup program: Hospitals made $1.3B+ in 340B profits—nearly $1B more than they spent on uncompensated care.

If patients aren’t benefiting, where is the money going?

Transparency and accountability are long overdue.

04/25/2026

America’s biopharmaceutical industry is a cornerstone of our economy and global leadership.

Companies have announced $500 billion in new U.S. investments, supporting jobs and communities nationwide. The U.S. also leads the world in R&D and is the first to introduce the majority of new medicines to patients.

At a time of rising global competition, policy decisions will determine whether that leadership continues.

On the Hill this week, we heard how insurers are standing between patients and the care their doctors prescribe.New data...
04/24/2026

On the Hill this week, we heard how insurers are standing between patients and the care their doctors prescribe.

New data from IQVIA shows that 70% of commercially insured patients were initially denied coverage for at least one newly prescribed medicine, forcing many to delay or abandon treatment altogether.

These are not isolated cases. Nearly 1 in 4 patients still are not approved after a year as administrative hurdles like prior authorization and step therapy continue to block access.

Patients should not face red tape when trying to access care. It is time for insurers to step up so patients come first.

https://phrma.org/blog/briefing-capitol-hill-panel-on-healthcare-denial-crisis-in-america

04/24/2026

Vaccines are one of the most effective tools to prevent disease, protect patients and reduce health care costs.

During World Immunization Week, Dr. Mike Ybarra highlights how vaccines have transformed public health and why that progress depends on continued use and a stable, science-based policy environment that supports innovation and access.

Read more on what is at stake for patients and future innovation: https://phrma.org/blog/world-immunization-week-putting-preventable-diseases-in-the-past

Address

670 Maine Avenue SW Ste. 1000
Washington D.C., DC
20024

Telephone

+12028353400

Website

Alerts

Be the first to know and let us send you an email when PhRMA posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to PhRMA:

Shortcuts

Featured

Share

Category